Badger Vaccines
Debate between George Eustice and Tracey Crouch(12 years, 3 months ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
George Eustice
I agree with my hon. Friend. I have painted a picture of how bleak the matter is. The disease is spreading and we cannot ignore it any more; we must take action.
Returning to vaccination, which is the subject of the debate, I think it is worth noting that successive Governments have invested more than £43 million on vaccine research and development since 1994. The coalition Government will have spent at least a further £15 million. I say “at least” because the figure excludes what is likely to be sizeable expenditure on the necessary work on cattle vaccine field trials.
Tracey Crouch
Is my hon. Friend aware that the response to a recent freedom of information request on 22 September shows a significant reduction in the amount of departmental investment in the oral vaccine particularly, but also in all other research into injectable vaccine and cattle vaccines? Spending on the oral vaccine will fall from around £2.5 million to £312,000 in 2015. Should that not be dealt with “drekly”, as the Cornish might say?
George Eustice
It seems that the word “drekly” is catching on in the House. I will deal with oral vaccination later. Right now, only the injectable BCG is available to tackle bovine TB and it does not fully guarantee protection. Some animals will be fully protected, some will benefit from a reduction in the disease, but some will get no protection. That is a shortcoming of a vaccination policy, but it would be a useful addition to the toolkit and we will use it to tackle the disease when we can perfect it.